<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30214595</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1792-1074</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>16</Volume>                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Oncology letters</Title>                <ISOAbbreviation>Oncol Lett</ISOAbbreviation>            </Journal>            <ArticleTitle>Texture features and pharmacokinetic parameters in differentiating benign and malignant breast lesions by dynamic contrast enhanced magnetic resonance imaging.</ArticleTitle>            <Pagination>                <MedlinePgn>4607-4613</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3892/ol.2018.9196</ELocationID>            <Abstract>                <AbstractText>Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) has become a powerful tool for the diagnosis of breast cancer in the clinical setting due to its high sensitivity and specificity. Pharmacokinetic parameters, including Ktrans and area under the curve (AUC), and texture features derived from DCE-MRI have been used to specify the characteristics inside tumors. In the present study, 56 patients (average age 45.3Â±11.1; range 25-69 years) with histopathologically proved breast tumors were analyzed using the pharmacokinetic parameters and texture features. Malignant tumors displayed higher Ktrans and AUC values than the benign, Ktrans exhibited a significantly difference between the malignant and benign tumors (P=0.001) compared with the AUC values (P=0.029); texture features from DCE-MRI images and pharmacokinetic parameter maps also showed a good diagnostic ability. Alongside the routine method, principal components analysis (PCA) and Fisher discriminant analysis (FDA) were employed on these texture features to differentiate the breast lesions automatically. The Factor-1 scores of PCA were used to divide the patients into two groups, and the diagnosing accuracies of the FDA method on the texture features from DCE-MRI images, Ktrans maps, AUC maps were 93, 98 and 98%, with a cross validation accuracies of 82, 77 and 77%, respectively. To conclude, pharmacokinetic parameters, texture features and the combined computer-assisted classification method were discussed. All method involved in this study may be a potential assisted tool for radiological analysis on breast.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Niu</LastName>                    <ForeName>Qingliang</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, WeiFang Traditional Chinese Hospital, Wei Fang, Shandong 255036, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jiang</LastName>                    <ForeName>Xiaomei</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, WeiFang Traditional Chinese Hospital, Wei Fang, Shandong 255036, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Qin</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, WeiFang Traditional Chinese Hospital, Wei Fang, Shandong 255036, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zheng</LastName>                    <ForeName>Zhaolong</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, WeiFang Traditional Chinese Hospital, Wei Fang, Shandong 255036, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Du</LastName>                    <ForeName>Hanwang</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, WeiFang Traditional Chinese Hospital, Wei Fang, Shandong 255036, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wu</LastName>                    <ForeName>Shasha</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, WeiFang Traditional Chinese Hospital, Wei Fang, Shandong 255036, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Xuexi</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>GE Healthcare, Shanghai 200000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>23</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Oncol Lett</MedlineTA>            <NlmUniqueID>101531236</NlmUniqueID>            <ISSNLinking>1792-1074</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Biomed Imaging. 2012;2012:676808</RefSource>                <PMID Version="1">23213317</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2008 Jan;246(1):116-24</RefSource>                <PMID Version="1">18024435</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Radiol. 2004 Dec;59(12):1061-9</RefSource>                <PMID Version="1">15556588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Magn Reson Imaging. 1999 Sep;10(3):223-32</RefSource>                <PMID Version="1">10508281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acad Radiol. 2010 Feb;17(2):135-41</RefSource>                <PMID Version="1">19945302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Magn Reson Imaging. 2016 Sep;34(7):896-901</RefSource>                <PMID Version="1">27109485</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2016 Sep;280(3):880-9</RefSource>                <PMID Version="1">27326665</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Appl Clin Med Phys. 2016 Sep 08;17(5):377-390</RefSource>                <PMID Version="1">27685105</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Imaging. 2015 Mar 21;15:4</RefSource>                <PMID Version="1">25889239</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Comput Assist Tomogr. 2015 May-Jun;39(3):383-95</RefSource>                <PMID Version="1">25700222</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 2015 Mar;114(3):345-50</RefSource>                <PMID Version="1">25746350</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prog Nucl Magn Reson Spectrosc. 2013 Oct;74:1-32</RefSource>                <PMID Version="1">24083460</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Spectrochim Acta A Mol Biomol Spectrosc. 2014 Mar 25;122:288-94</RefSource>                <PMID Version="1">24316544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Radiol. 2016 Sep;26(9):3034-45</RefSource>                <PMID Version="1">26679180</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Radiol. 2015 Oct;70(10):1128-35</RefSource>                <PMID Version="1">26152879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Med Imaging Rev. 2009 May 1;3(2):91-107</RefSource>                <PMID Version="1">19829742</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Jun 20;34(18):2157-64</RefSource>                <PMID Version="1">27138577</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Aug 07;9(8):e104066</RefSource>                <PMID Version="1">25102064</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>IEEE Trans Biomed Eng. 2013 Feb;60(2):343-53</RefSource>                <PMID Version="1">23193226</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Magn Reson Imaging. 2009 Nov;30(5):989-98</RefSource>                <PMID Version="1">19856419</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phys Med Biol. 2006 Jul 21;51(14):3593-602</RefSource>                <PMID Version="1">16825751</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Magn Reson Imaging. 2016 Jan;34(1):60-5</RefSource>                <PMID Version="1">26234500</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Mar 23;10(3):e0122053</RefSource>                <PMID Version="1">25799021</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Magn Reson Imaging. 2007 Jan;25(1):1-13</RefSource>                <PMID Version="1">17222711</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Radiol. 2000 Feb;55(2):99-109</RefSource>                <PMID Version="1">10657154</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Fisher discriminant analysis</Keyword>            <Keyword MajorTopicYN="N">dynamic contrast enhanced magnetic resonance imaging</Keyword>            <Keyword MajorTopicYN="N">pharmacokinetic parameters</Keyword>            <Keyword MajorTopicYN="N">principal component analysis</Keyword>            <Keyword MajorTopicYN="N">texture analysis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>12</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30214595</ArticleId>            <ArticleId IdType="doi">10.3892/ol.2018.9196</ArticleId>            <ArticleId IdType="pii">OL-0-0-9196</ArticleId>            <ArticleId IdType="pmc">PMC6126147</ArticleId>        </ArticleIdList>        <?pmcsd?>    </PubmedData></PubmedArticle></PubmedArticleSet>